{"pmid":32407669,"pmcid":"PMC7196896","title":"Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.","text":["Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.","The outbreaks of 2019 novel coronavirus disease (COVID-19) caused by SARS-CoV-2 infection have posed a severe threat to global public health. It is unclear how the human immune system responds to this infection. Here, we used metatranscriptomic sequencing to profile immune signatures in the bronchoalveolar lavage fluid of eight COVID-19 cases. The expression of proinflammatory genes, especially chemokines, was markedly elevated in COVID-19 cases compared to community-acquired pneumonia patients and healthy controls, suggesting that SARS-CoV-2 infection causes hypercytokinemia. Compared to SARS-CoV, which is thought to induce inadequate interferon (IFN) responses, SARS-CoV-2 robustly triggered expression of numerous IFN-stimulated genes (ISGs). These ISGs exhibit immunopathogenic potential, with overrepresentation of genes involved in inflammation. The transcriptome data was also used to estimate immune cell populations, revealing increases in activated dendritic cells and neutrophils. Collectively, these host responses to SARS-CoV-2 infection could further our understanding of disease pathogenesis and point toward antiviral strategies.","Cell Host Microbe","Zhou, Zhuo","Ren, Lili","Zhang, Li","Zhong, Jiaxin","Xiao, Yan","Jia, Zhilong","Guo, Li","Yang, Jing","Wang, Chun","Jiang, Shuai","Yang, Donghong","Zhang, Guoliang","Li, Hongru","Chen, Fuhui","Xu, Yu","Chen, Mingwei","Gao, Zhancheng","Yang, Jian","Dong, Jie","Liu, Bo","Zhang, Xiannian","Wang, Weidong","He, Kunlun","Jin, Qi","Li, Mingkun","Wang, Jianwei","32407669"],"abstract":["The outbreaks of 2019 novel coronavirus disease (COVID-19) caused by SARS-CoV-2 infection have posed a severe threat to global public health. It is unclear how the human immune system responds to this infection. Here, we used metatranscriptomic sequencing to profile immune signatures in the bronchoalveolar lavage fluid of eight COVID-19 cases. The expression of proinflammatory genes, especially chemokines, was markedly elevated in COVID-19 cases compared to community-acquired pneumonia patients and healthy controls, suggesting that SARS-CoV-2 infection causes hypercytokinemia. Compared to SARS-CoV, which is thought to induce inadequate interferon (IFN) responses, SARS-CoV-2 robustly triggered expression of numerous IFN-stimulated genes (ISGs). These ISGs exhibit immunopathogenic potential, with overrepresentation of genes involved in inflammation. The transcriptome data was also used to estimate immune cell populations, revealing increases in activated dendritic cells and neutrophils. Collectively, these host responses to SARS-CoV-2 infection could further our understanding of disease pathogenesis and point toward antiviral strategies."],"journal":"Cell Host Microbe","authors":["Zhou, Zhuo","Ren, Lili","Zhang, Li","Zhong, Jiaxin","Xiao, Yan","Jia, Zhilong","Guo, Li","Yang, Jing","Wang, Chun","Jiang, Shuai","Yang, Donghong","Zhang, Guoliang","Li, Hongru","Chen, Fuhui","Xu, Yu","Chen, Mingwei","Gao, Zhancheng","Yang, Jian","Dong, Jie","Liu, Bo","Zhang, Xiannian","Wang, Weidong","He, Kunlun","Jin, Qi","Li, Mingkun","Wang, Jianwei"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407669","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.chom.2020.04.017","keywords":["bronchoalveolar lavage fluid","covid-19","chemokines","coronavirus","hypercytokinemia","innate immune response","interferon response","interferon-stimulated genes","metatranscriptomic sequencing","sars-cov-2"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666950579744669696,"score":9.490897,"similar":[{"pmid":32463434,"title":"Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling.","text":["Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling.","BACKGROUND: The recent identification of a novel coronavirus, also known as SARS-CoV-2, has caused a global outbreak of respiratory illnesses. The rapidly developing pandemic has posed great challenges to diagnosis of this novel infection. However, little is known about the metatranscriptomic characteristics of patients with Coronavirus Disease 2019 (COVID-19). METHODS: We analyzed metatranscriptomics in 187 patients (62 cases with COVID-19 and 125 with non-COVID-19 pneumonia). Transcriptional aspects of three core elements - pathogens, the microbiome, and host responses - were interrogated. Based on the host transcriptional signature, we built a host gene classifier and examined its potential for diagnosing COVID-19 and indicating disease severity. RESULTS: The airway microbiome in COVID-19 patients had reduced alpha diversity, with 18 taxa of differential abundance. Potentially pathogenic microbes were also detected in 47% of the COVID-19 cases, 58% of which were respiratory viruses. Host gene analysis revealed a transcriptional signature of 36 differentially expressed genes significantly associated with immune pathways such as cytokine signaling. The host gene classifier built on such a signature exhibited potential for diagnosing COVID-19 (AUC of 0.75-0.89) and indicating disease severity. CONCLUSIONS: Compared to those with non-COVID-19 pneumonias, COVID-19 patients appeared to have a more disrupted airway microbiome with frequent potential concurrent infections, and a special trigger host immune response in certain pathways such as interferon gamma signaling. The immune-associated host transcriptional signatures of COVID-19 hold promise as a tool for improving COVID-19 diagnosis and indicating disease severity.","Clin Infect Dis","Zhang, Haocheng","Ai, Jing-Wen","Yang, Wenjiao","Zhou, Xian","He, Fusheng","Xie, Shumei","Zeng, Weiqi","Li, Yang","Yu, Yiqi","Gou, Xuejing","Li, Yongjun","Wang, Xiaorui","Su, Hang","Xu, Teng","Zhang, Wenhong","32463434"],"abstract":["BACKGROUND: The recent identification of a novel coronavirus, also known as SARS-CoV-2, has caused a global outbreak of respiratory illnesses. The rapidly developing pandemic has posed great challenges to diagnosis of this novel infection. However, little is known about the metatranscriptomic characteristics of patients with Coronavirus Disease 2019 (COVID-19). METHODS: We analyzed metatranscriptomics in 187 patients (62 cases with COVID-19 and 125 with non-COVID-19 pneumonia). Transcriptional aspects of three core elements - pathogens, the microbiome, and host responses - were interrogated. Based on the host transcriptional signature, we built a host gene classifier and examined its potential for diagnosing COVID-19 and indicating disease severity. RESULTS: The airway microbiome in COVID-19 patients had reduced alpha diversity, with 18 taxa of differential abundance. Potentially pathogenic microbes were also detected in 47% of the COVID-19 cases, 58% of which were respiratory viruses. Host gene analysis revealed a transcriptional signature of 36 differentially expressed genes significantly associated with immune pathways such as cytokine signaling. The host gene classifier built on such a signature exhibited potential for diagnosing COVID-19 (AUC of 0.75-0.89) and indicating disease severity. CONCLUSIONS: Compared to those with non-COVID-19 pneumonias, COVID-19 patients appeared to have a more disrupted airway microbiome with frequent potential concurrent infections, and a special trigger host immune response in certain pathways such as interferon gamma signaling. The immune-associated host transcriptional signatures of COVID-19 hold promise as a tool for improving COVID-19 diagnosis and indicating disease severity."],"journal":"Clin Infect Dis","authors":["Zhang, Haocheng","Ai, Jing-Wen","Yang, Wenjiao","Zhou, Xian","He, Fusheng","Xie, Shumei","Zeng, Weiqi","Li, Yang","Yu, Yiqi","Gou, Xuejing","Li, Yongjun","Wang, Xiaorui","Su, Hang","Xu, Teng","Zhang, Wenhong"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463434","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1093/cid/ciaa663","keywords":["covid-19","concurrent infection","host responses","metatranscriptomics","sars-cov-2"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668079521258012672,"score":301.56403},{"pmid":32416070,"title":"Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.","text":["Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.","Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.","Cell","Blanco-Melo, Daniel","Nilsson-Payant, Benjamin E","Liu, Wen-Chun","Uhl, Skyler","Hoagland, Daisy","Moller, Rasmus","Jordan, Tristan X","Oishi, Kohei","Panis, Maryline","Sachs, David","Wang, Taia T","Schwartz, Robert E","Lim, Jean K","Albrecht, Randy A","tenOever, Benjamin R","32416070"],"abstract":["Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19."],"journal":"Cell","authors":["Blanco-Melo, Daniel","Nilsson-Payant, Benjamin E","Liu, Wen-Chun","Uhl, Skyler","Hoagland, Daisy","Moller, Rasmus","Jordan, Tristan X","Oishi, Kohei","Panis, Maryline","Sachs, David","Wang, Taia T","Schwartz, Robert E","Lim, Jean K","Albrecht, Randy A","tenOever, Benjamin R"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416070","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.cell.2020.04.026","keywords":["covid-19","coronavirus","il6","sars-cov-2","chemokines","ferret","interferon","transcriptomics","virus-host interactions"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666991242631708672,"score":259.7503},{"pmid":32228226,"pmcid":"PMC7170362","title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.","text":["Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.","Circulating in China and 158 other countries and areas, the ongoing COVID-19 outbreak has caused devastating mortality and posed a great threat to public health. However, efforts to identify effectively supportive therapeutic drugs and treatments has been hampered by our limited understanding of host immune response for this fatal disease. To characterize the transcriptional signatures of host inflammatory response to SARS-CoV-2 (HCoV-19) infection, we carried out transcriptome sequencing of the RNAs isolated from the bronchoalveolar lavage fluid (BALF) and peripheral blood mononuclear cells (PBMC) specimens of COVID-19 patients. Our results reveal distinct host inflammatory cytokine profiles to SARS-CoV-2 infection in patients, and highlight the association between COVID-19 pathogenesis and excessive cytokine release such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B. Furthermore, SARS-CoV-2 induced activation of apoptosis and P53 signalling pathway in lymphocytes may be the cause of patients' lymphopenia. The transcriptome dataset of COVID-19 patients would be a valuable resource for clinical guidance on anti-inflammatory medication and understanding the molecular mechansims of host response.","Emerg Microbes Infect","Xiong, Yong","Liu, Yuan","Cao, Liu","Wang, Dehe","Guo, Ming","Jiang, Ao","Guo, Dong","Hu, Wenjia","Yang, Jiayi","Tang, Zhidong","Wu, Honglong","Lin, Yongquan","Zhang, Meiyuan","Zhang, Qi","Shi, Mang","Liu, Yingle","Zhou, Yu","Lan, Ke","Chen, Yu","32228226"],"abstract":["Circulating in China and 158 other countries and areas, the ongoing COVID-19 outbreak has caused devastating mortality and posed a great threat to public health. However, efforts to identify effectively supportive therapeutic drugs and treatments has been hampered by our limited understanding of host immune response for this fatal disease. To characterize the transcriptional signatures of host inflammatory response to SARS-CoV-2 (HCoV-19) infection, we carried out transcriptome sequencing of the RNAs isolated from the bronchoalveolar lavage fluid (BALF) and peripheral blood mononuclear cells (PBMC) specimens of COVID-19 patients. Our results reveal distinct host inflammatory cytokine profiles to SARS-CoV-2 infection in patients, and highlight the association between COVID-19 pathogenesis and excessive cytokine release such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B. Furthermore, SARS-CoV-2 induced activation of apoptosis and P53 signalling pathway in lymphocytes may be the cause of patients' lymphopenia. The transcriptome dataset of COVID-19 patients would be a valuable resource for clinical guidance on anti-inflammatory medication and understanding the molecular mechansims of host response."],"journal":"Emerg Microbes Infect","authors":["Xiong, Yong","Liu, Yuan","Cao, Liu","Wang, Dehe","Guo, Ming","Jiang, Ao","Guo, Dong","Hu, Wenjia","Yang, Jiayi","Tang, Zhidong","Wu, Honglong","Lin, Yongquan","Zhang, Meiyuan","Zhang, Qi","Shi, Mang","Liu, Yingle","Zhou, Yu","Lan, Ke","Chen, Yu"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32228226","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1080/22221751.2020.1747363","keywords":["covid-19","cytokine","inflammation","lymphopenia","transcriptome profiling"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138492195831810,"score":257.7782},{"pmid":32364527,"title":"Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.","text":["Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.","Currently, we are on a global pandemic of Coronavirus disease-2019 (COVID-19) which causes fever, dry cough, fatigue and acute respiratory distress syndrome (ARDS) that may ultimately lead to the death of the infected. Current researches on COVID-19 continue to highlight the necessity for further understanding the virus-host synergies. In this study, we have highlighted the key cytokines induced by coronavirus infections. We have demonstrated that genes coding interleukins (Il-1alpha, Il-1beta, Il-6, Il-10), chemokine (Ccl2, Ccl3, Ccl5, Ccl10), and interferon (Ifn-alpha2, Ifn-beta1, Ifn2) upsurge significantly which in line with the elevated infiltration of T cells, NK cells and monocytes in SARS-Cov treated group at 24 hours. Also, interleukins (IL-6, IL-23alpha, IL-10, IL-7, IL-1alpha, IL-1beta) and interferon (IFN-alpha2, IFN2, IFN-gamma) have increased dramatically in MERS-Cov at 24 hours. A similar cytokine profile showed the cytokine storm served a critical role in the infection process. Subsequent investigation of 463 patients with COVID-19 disease revealed the decreased amount of total lymphocytes, CD3+, CD4+, and CD8+ T lymphocytes in the severe type patients which indicated COVID-19 can impose hard blows on human lymphocyte resulting in lethal pneumonia. Thus, taking control of changes in immune factors could be critical in the treatment of COVID-19.","Aging (Albany NY)","Yao, Zhixian","Zheng, Zhong","Wu, Ke","Junhua, Zheng","32364527"],"abstract":["Currently, we are on a global pandemic of Coronavirus disease-2019 (COVID-19) which causes fever, dry cough, fatigue and acute respiratory distress syndrome (ARDS) that may ultimately lead to the death of the infected. Current researches on COVID-19 continue to highlight the necessity for further understanding the virus-host synergies. In this study, we have highlighted the key cytokines induced by coronavirus infections. We have demonstrated that genes coding interleukins (Il-1alpha, Il-1beta, Il-6, Il-10), chemokine (Ccl2, Ccl3, Ccl5, Ccl10), and interferon (Ifn-alpha2, Ifn-beta1, Ifn2) upsurge significantly which in line with the elevated infiltration of T cells, NK cells and monocytes in SARS-Cov treated group at 24 hours. Also, interleukins (IL-6, IL-23alpha, IL-10, IL-7, IL-1alpha, IL-1beta) and interferon (IFN-alpha2, IFN2, IFN-gamma) have increased dramatically in MERS-Cov at 24 hours. A similar cytokine profile showed the cytokine storm served a critical role in the infection process. Subsequent investigation of 463 patients with COVID-19 disease revealed the decreased amount of total lymphocytes, CD3+, CD4+, and CD8+ T lymphocytes in the severe type patients which indicated COVID-19 can impose hard blows on human lymphocyte resulting in lethal pneumonia. Thus, taking control of changes in immune factors could be critical in the treatment of COVID-19."],"journal":"Aging (Albany NY)","authors":["Yao, Zhixian","Zheng, Zhong","Wu, Ke","Junhua, Zheng"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32364527","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.18632/aging.103101","keywords":["covid-19","sars-cov-2","cytokine storm"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495984336897,"score":253.94234},{"pmid":32413319,"title":"SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.","text":["SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.","There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-CoV-2 spike (S) protein binds angiotensin-converting enzyme 2 (ACE2), and in concert with host proteases, principally transmembrane serine protease 2 (TMPRSS2), promotes cellular entry. The cell subsets targeted by SARS-CoV-2 in host tissues and the factors that regulate ACE2 expression remain unknown. Here, we leverage human, non-human primate, and mouse single-cell RNA-sequencing (scRNA-seq) datasets across health and disease to uncover putative targets of SARS-CoV-2 among tissue-resident cell subsets. We identify ACE2 and TMPRSS2 co-expressing cells within lung type II pneumocytes, ileal absorptive enterocytes, and nasal goblet secretory cells. Strikingly, we discovered that ACE2 is a human interferon-stimulated gene (ISG) in vitro using airway epithelial cells and extend our findings to in vivo viral infections. Our data suggest that SARS-CoV-2 could exploit species-specific interferon-driven upregulation of ACE2, a tissue-protective mediator during lung injury, to enhance infection.","Cell","Ziegler, Carly G K","Allon, Samuel J","Nyquist, Sarah K","Mbano, Ian M","Miao, Vincent N","Tzouanas, Constantine N","Cao, Yuming","Yousif, Ashraf S","Bals, Julia","Hauser, Blake M","Feldman, Jared","Muus, Christoph","Wadsworth, Marc H 2nd","Kazer, Samuel W","Hughes, Travis K","Doran, Benjamin","Gatter, G James","Vukovic, Marko","Taliaferro, Faith","Mead, Benjamin E","Guo, Zhiru","Wang, Jennifer P","Gras, Delphine","Plaisant, Magali","Ansari, Meshal","Angelidis, Ilias","Adler, Heiko","Sucre, Jennifer M S","Taylor, Chase J","Lin, Brian","Waghray, Avinash","Mitsialis, Vanessa","Dwyer, Daniel F","Buchheit, Kathleen M","Boyce, Joshua A","Barrett, Nora A","Laidlaw, Tanya M","Carroll, Shaina L","Colonna, Lucrezia","Tkachev, Victor","Peterson, Christopher W","Yu, Alison","Zheng, Hengqi Betty","Gideon, Hannah P","Winchell, Caylin G","Lin, Philana Ling","Bingle, Colin D","Snapper, Scott B","Kropski, Jonathan A","Theis, Fabian J","Schiller, Herbert B","Zaragosi, Laure-Emmanuelle","Barbry, Pascal","Leslie, Alasdair","Kiem, Hans-Peter","Flynn, JoAnne L","Fortune, Sarah M","Berger, Bonnie","Finberg, Robert W","Kean, Leslie S","Garber, Manuel","Schmidt, Aaron G","Lingwood, Daniel","Shalek, Alex K","Ordovas-Montanes, Jose","32413319"],"abstract":["There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-CoV-2 spike (S) protein binds angiotensin-converting enzyme 2 (ACE2), and in concert with host proteases, principally transmembrane serine protease 2 (TMPRSS2), promotes cellular entry. The cell subsets targeted by SARS-CoV-2 in host tissues and the factors that regulate ACE2 expression remain unknown. Here, we leverage human, non-human primate, and mouse single-cell RNA-sequencing (scRNA-seq) datasets across health and disease to uncover putative targets of SARS-CoV-2 among tissue-resident cell subsets. We identify ACE2 and TMPRSS2 co-expressing cells within lung type II pneumocytes, ileal absorptive enterocytes, and nasal goblet secretory cells. Strikingly, we discovered that ACE2 is a human interferon-stimulated gene (ISG) in vitro using airway epithelial cells and extend our findings to in vivo viral infections. Our data suggest that SARS-CoV-2 could exploit species-specific interferon-driven upregulation of ACE2, a tissue-protective mediator during lung injury, to enhance infection."],"journal":"Cell","authors":["Ziegler, Carly G K","Allon, Samuel J","Nyquist, Sarah K","Mbano, Ian M","Miao, Vincent N","Tzouanas, Constantine N","Cao, Yuming","Yousif, Ashraf S","Bals, Julia","Hauser, Blake M","Feldman, Jared","Muus, Christoph","Wadsworth, Marc H 2nd","Kazer, Samuel W","Hughes, Travis K","Doran, Benjamin","Gatter, G James","Vukovic, Marko","Taliaferro, Faith","Mead, Benjamin E","Guo, Zhiru","Wang, Jennifer P","Gras, Delphine","Plaisant, Magali","Ansari, Meshal","Angelidis, Ilias","Adler, Heiko","Sucre, Jennifer M S","Taylor, Chase J","Lin, Brian","Waghray, Avinash","Mitsialis, Vanessa","Dwyer, Daniel F","Buchheit, Kathleen M","Boyce, Joshua A","Barrett, Nora A","Laidlaw, Tanya M","Carroll, Shaina L","Colonna, Lucrezia","Tkachev, Victor","Peterson, Christopher W","Yu, Alison","Zheng, Hengqi Betty","Gideon, Hannah P","Winchell, Caylin G","Lin, Philana Ling","Bingle, Colin D","Snapper, Scott B","Kropski, Jonathan A","Theis, Fabian J","Schiller, Herbert B","Zaragosi, Laure-Emmanuelle","Barbry, Pascal","Leslie, Alasdair","Kiem, Hans-Peter","Flynn, JoAnne L","Fortune, Sarah M","Berger, Bonnie","Finberg, Robert W","Kean, Leslie S","Garber, Manuel","Schmidt, Aaron G","Lingwood, Daniel","Shalek, Alex K","Ordovas-Montanes, Jose"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32413319","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.cell.2020.04.035","keywords":["ace2","covid-19","isg","sars-cov-2","human","influenza","interferon","mouse","non-human primate","scrna-seq"],"locations":["Tissues"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666897319120863233,"score":249.91365}]}